Numerix Signs OTP for OTC Analytics

budapest
OTP Bank is based in Budapest, Hungary (pictured)

OTP Bank, a Hungary-based bank focusing on Central and Eastern Europe, is to roll out over-the-counter pricing and analytics software provider Numerix's CrossAsset solution to support derivatives analytics across its firm by validating models, pricing complex derivatives, and performing pre- and post-trade analysis, including Greeks, scenarios and stress tests.

Officials say implementing CrossAsset allows the bank to assess model risk, reduce operational risk, and validate prices of structured products for more profitable trading and more transparent reporting.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

The AI boom proves a boon for chief data officers

Voice of the CDO: As trading firms incorporate AI and large language models into their investment workflows, there’s a growing realization among firms that their data governance structures are riddled with holes. Enter the chief data officer.

If M&A picks up, who’s on the auction block?

Waters Wrap: With projections that mergers and acquisitions are geared to pick back up in 2025, Anthony reads the tea leaves of 25 of this year’s deals to predict which vendors might be most valuable.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here